Summary by Moomoo AI
New Ray Medicine International Holdings Limited (the "Company") announced on October 16, 2024, that Mr. Ho Chi Hong, an executive director, has resigned from his position as an executive director and a member of the board of directors' Corporate Governance Committee due to other business pursuits and commitments. Mr. Ho's resignation will prompt a reorganization of the Corporate Governance Committee, with the new composition being chaired by Ms. Wang Qiuyin, and Mr. Shi Lixian and Ms. Zhou Wan as members. Mr. Ho has confirmed no disagreements with the board of directors and no matters requiring reporting to shareholders or the Hong Kong Stock Exchange. The board of directors expresses gratitude to Mr. Ho for his contributions to the company during his tenure.
